Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?

We believe that some further comment would be appropriate about the interesting systematic review and meta-analysis on the effects of anticoagulants in patients with cirrhosis and portal vein thrombosis (PVT), recently published in Gastroenterology.1 Overall, the study reports that anticoagulants increased recanalization and reduced progression of thrombosis, compared with patients who did not receive anticoagulants, with no excess of major and minor bleedings, and a lesser incidence of variceal bleeding.

This entry was posted in News. Bookmark the permalink.